Physician profile
John C Edwards
NPI 1942341706
$1,448.35
in general payments reported to CMS, 2019-2025
12 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $36.74 · 2021: $546 · 2022: $112 · 2023: $238 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexus Spine, LLC | $306.95 | 2021 | |
| Depuy Synthes Sales INC. | $291.31 | 2021-2023 | Na, Dynaforce |
| Boston Scientific Corporation | $269.86 | 2019-2021 | |
| Centinel Spine, LLC | $164.19 | 2025 | Prodisc L |
| Zimmer Biomet Holdings, INC. | $149.37 | 2020-2023 | |
| Orthofix Medical, INC. | $98.93 | 2022 | |
| Camber Spine Technologies LLC | $74.95 | 2019 | |
| Stryker Corporation | $24.45 | 2021 | |
| Medtronic USA, INC. | $22.34 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.49 | 2025 | Exparel |
| Active Medical, LLC | $16.32 | 2025 | |
| Ferring Pharmaceuticals INC. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.